Since its opening in 2000, this IGBMC technological platform is dedicated to providing researchers access to state-of-the-art high throughput technologies to survey genomes, their expression and their regulation. Our objective is to offer full services from quality check of starting material up to data analysis using standardized methodologies. Our facility is involved in several national projects including “France Génomique” and is open to all french and international academic and industrial research community.
We provide comprehensive services for two complementary technologies: Illumina high-throughput sequencing (HiSeq 4000) and Affymetrix DNA microarrays. We routinely perform ChIP-seq, Genomic-seq and RNA-seq analyses using a large variety of protocols and we have developed dedicated bioinformatic pipelines to analyse the corresponding results. Using microarrays, the almost exclusive application is transcriptome profiling.
More recently, we have expanded our technology portfolio by the innovative Fluidigm Biomark™ and C1™ Single-Cell Auto Prep systems. These equipments are currently made available to researchers, on a self-service basis, to study gene expression down to the single-cell level by Q-PCR or RNA-seq. Our objective is to offer full services for these applications as well early 2016.
The primary goal of our facility is to provide customers with the best data and services to help them conduct high-level scientific research. For that purpose, we have implemented working and organizational procedures that follow the guidelines of the quality management norm ISO 9001. In January 2007, our platform has been certified by the independent LRQA organism (Lloyd's Register Quality Assurance) to comply to the 2000 version of this norm. This certification has been renewed in 2010 for the ISO 9001 v2008 norm. Since January 2016, it has been double certified ISO 9001:2008 and NFX 50-900.
Last update on Thursday 26 May 2016